Decision based on narrow band imaging cystoscopy without a referential normal standard rather increases unnecessary biopsy in detection of recurrent bladder urothelial carcinoma early after intravesical instillation

Cancer Research and Treatment

Volumn 48, Issue 1, 2016, Pages 273-280

  Song, Phil Hyun ^a   Cho, Seok ^b   Ko, Young Hwii ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Cystoscopy; Narrow band imaging; Urinary bladder neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CYSTOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NARROW BAND IMAGING; NARROW BAND IMAGING CYSTOSCOPY; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; UROGENITAL ENDOSCOPY; WHITE LIGHT CYSTOSCOPY; BIOPSY; BLADDER TUMOR; INTRAVESICAL DRUG ADMINISTRATION; MIDDLE AGED; STANDARD; STANDARDS; TUMOR RECURRENCE; UTILIZATION;

ADMINISTRATION, INTRAVESICAL; AGED; BIOPSY; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NARROW BAND IMAGING; NEOPLASM RECURRENCE, LOCAL; REFERENCE STANDARDS; URINARY BLADDER NEOPLASMS;

EID: 84957588387     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2014.190     Document Type: Article

References (25)

1. Geavlete B, Stanescu F, Moldoveanu C, Jecu M, Adou L, Bulai C, et al. NBI cystoscopy and bipolar electrosurgery in NMIBC management: an overview of daily practice. J Med Life. 2013;6:140-5.
2. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64:639-53.
3. Zheng C, Lv Y, Zhong Q, Wang R, Jiang Q. Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int. 2012;110(11 Pt B):E680-7.
4. Tatsugami K, Kuroiwa K, Kamoto T, Nishiyama H, Watanabe J, Ishikawa S, et al. Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol. 2010;24:1807-11.
5. Bryan RT, Billingham LJ, Wallace DM. Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int. 2008;101:702-5.
6. Naselli A, Introini C, Bertolotto F, Spina B, Puppo P. Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int. 2010;105:208-11.
7. Geavlete B, Multescu R, Georgescu D, Stanescu F, Jecu M, Geavlete P. Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors: results of a prospective, randomized comparison to the standard approach. Urology. 2012;79:846-51.
8. Li K, Lin T, Fan X, Duan Y, Huang J. Diagnosis of narrowband imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol. 2013;20:602-9.
9. Herr HW, Donat SM. A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int. 2008;102:1111-4.
10. Cauberg EC, Kloen S, Visser M, de la Rosette JJ, Babjuk M, Soukup V, et al. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology. 2010;76:658-63.
11. Naselli A, Introini C, Timossi L, Spina B, Fontana V, Pezzi R, et al. A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol. 2012;61:908-13.
12. Herr HW, Donat SM. Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy. BJU Int. 2011;107:396-8.
13. Patel JV, Chambers CV, Gomella LG. Hematuria: etiology and evaluation for the primary care physician. Can J Urol. 2008;15 Suppl 1:54-61.
14. Messing EM, Young TB, Hunt VB, Gilchrist KW, Newton MA, Bram LL, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology. 1995;45:387-96.
15. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473-81.
16. Liu JJ, Droller MJ, Liao JC. New optical imaging technologies for bladder cancer: considerations and perspectives. J Urol. 2012;188:361-8.
17. Herr HH. Narrow band imaging cystoscopy. Urol Oncol. 2011;29:353-7.
18. Jichlinski P, Leisinger HJ. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! Urol Int. 2005;74:97-101.
19. Naito S, van Rees Vellinga S, de la Rosette J. Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients. J Endourol. 2013;27:1-3.
20. Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, et al. Appearance of enhanced tissue features in narrowband endoscopic imaging. J Biomed Opt. 2004;9:568-77.
21. Herr HW. Narrow-band imaging cystoscopy to evaluate the response to bacilli Calmette-Guerin therapy: preliminary results. BJU Int. 2010;105:314-6.
22. Herr H, Donat M, Dalbagni G, Taylor J. Narrow-band imaging cystoscopy to evaluate bladder tumours: individual surgeon variability. BJU Int. 2010;106:53-5.
23. Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, et al. Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. J Urol. 2010;184:1907-13.
24. Schumacher MC, Holmang S, Davidsson T, Friedrich B, Pedersen J, Wiklund NP. Transurethral resection of nonmuscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol. 2010;57:293-9.
25. Stenzl A, Penkoff H, Dajc-Sommerer E, Zumbraegel A, Hoeltl L, Scholz M, et al. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled trial. Cancer. 2011;117:938-47.